Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor κB and ets

Hypertension

Volumn 48, Issue 4, 2006, Pages 628-636

  Shiraya, Suguru ^a,b   Miwa, Ken ^a,b   Aoki, Motokuni ^a   Miyake, Takashi ^a   Oishi, Masako ^c   Kataoka, Kazusaburo ^c   Ohgi, Shigetsugu ^b   Ogihara, Toshio ^a   Kaneda, Yasufumi ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Abdominal aortic aneurysm; Decoy; Ets; Hypertension; MMP; NF B

Indexed keywords

CELL ADHESION MOLECULE; ELASTASE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE ELASTASE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN; PROTEIN ETS; STROMELYSIN; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; NF KAPPAB DECOY; NF-KAPPAB DECOY; OLIGODEOXYRIBONUCLEOTIDE; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR ETS;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA TRANSFECTION; ECHOGRAPHY; ENZYME ACTIVITY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION; MALE; NEPHRECTOMY; NONHUMAN; ORGAN CULTURE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MACROPHAGE; METABOLISM; PATHOPHYSIOLOGY; TIME; WISTAR RAT;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; CELL MOVEMENT; DISEASE PROGRESSION; HYPERTENSION; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGES; MALE; MATRIX METALLOPROTEINASES; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES; PROTO-ONCOGENE PROTEINS C-ETS; RATS; RATS, WISTAR; TIME FACTORS; UP-REGULATION;

EID: 33750585729     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000240266.26185.57     Document Type: Article

References (49)

1. Cole CW. Proceedings of the workshop on the control of abdominal aortic aneurysm. Chronic Dis Can. 1994;15:S1-S64.
2. Van der Vliet JA, Boll APM. Abdominal aortic aneurysm [seminar]. Lancet. 1997;349:863-866.
3. Collin J. The epidemiology of abdominal aortic aneurysm. Br J Hosp Med. 1988;40:65-68.
4. Norrgard O, Angquist K, Johnson O. Familial aortic aneurysms: serum concentrations of triglyceride, cholesterol, HDL-cholesterol and (VSLD+LDL)-cholesterol. Br J Surg. 1985;72:113-116.
5. MacSweeney STR, Powell JT, Greenhalg RM. Pathogenesis of abdominal aortic aneurysm. Br J Surg. 1994;81:935-941.
6. Thompson RW. Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. Curr Opin Cardiol. 1996;11:504-518.
7. Alcorn HG, Wolfson SK, Sutton-Tyrrell K, Kuller LH, O'Leary DH. Risk factors for abdominal aortic aneurysms in older adults enrolled in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1996;16:963-970.
8. Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC, Barone GW, Acher CW, Ballard DJ, for the Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Prevalence and associations of abdominal aortic aneurysm detected through screening. Ann Intern Med. 1997;126:441-449.
9. Lindholm L, Ejlertsson G, Forsberg L, Norgren L. Low prevalence of abdominal aortic aneurysm in hypertensive patients. Acta Med Scand. 1985;218:305-310.
10. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalg PM, Powell JT. Inflammation and matrix metalloproteinases in enlarging abdominal aortic aneurysm. Arterioscler Thromb. 1995;15:1145-1151.
11. Newman KM, Jean-Claude J, Hong L, Ramey WG, Tilson MD. Cytokines that activate proteolysis are elevated in abdominal aortic aneurysm. Circulation. 1994;90:224-227.
12. Szekanecz Z, Shah MR, Pearce WH, Koch AE. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4; The possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions. 1994;42:159-162.
13. Shah PK. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation. 1997;96:2115-2117.
14. Busuttil RW, Rinderbriecht H, Flesher A, Carmack C. Elastase activity: The role of elastase in aortic aneurysm formation. J Surg Res. 1982;32:214-217.
15. Cohen JR, Mandell C, Margolis I, Chang J, Wise L. Altered aortic protease and antiprotease activity in patients with ruptured abdominal aortic aneurysms. Surg Gynecol Obstet. 1987;164:355-358.
16. Ibrahim HN, Hostetter TH. The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol. 1998;9:72-76.
17. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg. 1996;23:336-346.
18. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000;105:1641-1649.
19. Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M, Jo N, Oishi M, Kataoka K, Ohgi S, Ogihara T, Kaneda Y, Morishita R. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of NFκB and ets transcription factors. Circulation. 2004;109:132-138.
20. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T. In vivo transfection of cis element "decoy" against NFκB binding site prevented myocardial infarction as gene therapy. Nat Med. 1997;3:894-899.
21. Ohishi M, Ueda M, Rakugi H, Okamura A, Naruko T, Becker AE, Hiwada K, Kamitani A, Kamide K, Higaki J, Ogihara T. Upregulation of angiotensin- converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation. 1997;96:3328-3337.
22. Goodall S, Crowther M, Hemingway DM, Bell PR, Thompson MM. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation. 2001;104:304-309.
23. Miwa K, Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M, Oishi M, Kataoka K, Ohgi S, Ogihara T, Kaneda Y, Morishita R. Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Gene Ther. 2005;12:1109-1118.
24. Miyake T, Aoki M, Nakashima H, Kawasaki T, Oishi S, Kataoka K, Tanemoto K, Ogihara T, Kaneda Y, Morishita R. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model. Gene Ther. 2006;13:695-704.
25. Li JJ, Fang CH, Hui RT. Is hypertension an inflammatory disease? Med Hypotheses. 2005;64:236-240.
26. Rodriguez-Iturbe B, Quiroz Y, Ferrebuz A, Parra G, Vaziri ND. Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats. Am J Nephrol. 2004;24:587-594.
27. Pearce WH, Sweis I, Yao JST, Mac Carthy WJ, Koch AE. Interleukin-1 and tumour necrosis factor-alfa release in normal and diseased human infrarenal aortas. J Vasc Surg. 1992;16:784-789.
28. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikh D, Evanoff HL, Haines GK, Burdick MD, Strieter RM. Enhanced production of chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysm. Am J Pathol. 1993;142:1423-1431.
29. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625-632.
30. Ishibashi M, Egashira K, Zhao Q, Hiasa K, Ohtani K, Ihara Y, Charo IF, Kura S, Tsuzuki T, Takeshita A, Sunagawa K. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol. 2004;24:174-178.
31. Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation. 2004;110:862-866.
32. Vainas T, Lubbers T, Stassen FR, Herngreen SB, van Dieijen-Visser MP, Bruggeman CA, Kitslaar PJ, Schurink GW. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003;107:1103-1105.
33. Miralles M, Wester W, Sicard GA, Thompson R, Reilly JM. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg. 1999;29:884-892.
34. Tayebjee MH, Nadar S, Blann AD, Gareth Beevers D, MacFadyen RJ, Lip GY. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am J Hypertens. 2004;17:764-769.
35. Agabiti Rosei E, Morelli P, Rizzoni D. Effects of nifedipine GITS 20 mg or enalapril 20 mg on blood pressure and inflammatory markers in patients with mild-moderate hypertension. Blood Press Suppl. 2005;1:14-22.
36. Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2005;315:51-57.
37. Kuwahara F, Kai H, Tokuda K, Shibata R, Kusaba K, Tahara N, Niiyama H, Nagata T, Imaizumi T. Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension. 2002;39:46-50.
38. Landry DB, Couper LL, Bryant SR, Lindner V. Activation of the NF-κB and I-κB system in smooth muscle cells after rat arterial injury: Induction of vascular cell adhesion molecule-1 and monocyte chemotactic protein-1. Am J Pathol. 1997;151:1085-1095.
39. Yamasaki K, Asai T, Shimizu M, Aoki M, Hashiya N, Sakonjo H, Makino H, Kaneda Y, Ogihara T, Morishita R. Inhibition of NFκB activation using cis-element "decoy" of NFκB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Ther. 2003;10:356-364.
40. Tomita N, Morishita R, Tomita S, Yamamoto K, Aoki M, Matsushita H, Hayashi S, Higaki J, Ogihara T. Transcription factor decoy for NFκB inhibits TNF-α-induced IL-6 and ICAM-1 expression in endothelial cells. J Hypertens. 1998;16:993-1000.
41. Bond M, Baker AH, Newby AC. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochem Biophys Res Commun. 1999;264:561-567.
42. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995;96:318-326.
43. Newman KM, Jean-Claude J, Li H, Scholes JV, Ogata Y, Nagase H, Tilson MD. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg. 1994;20:814-820.
44. Vandenbunder B, Wernert N, Queva C, Desbiens X, Stehelin D. Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion? Folia Biol Praha. 1994;40:301-313.
45. Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H, Seiki M, Ishii S, Fujinaga K. The ets-1 and ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer. 1998;77:128-137.
46. Peters CL, Morris CJ, Mapp PI, Blake DR, Lewis CE, Winrow VR. The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum. 2004;50:291-296.
47. Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z. Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors. Biochem Soc Trans. 2004;32:88-91.
48. Novitskiy G, Potter JJ, Rennie-Tankersley L, Mezey E. Identification of a novel NF-kappaB-binding site with regulation of the murine alpha2(I) collagen promoter. J Biol Chem. 2004:9;279:15639-15644.
49. Seguin CA, Bernier SM. TNFalpha suppresses link protein and type II collagen expression in chondrocytes: role of MEK1/2 and NF-kappaB signaling pathways. J Cell Physiol. 2003;197:356-369.